RIPK4 and urinary bladder cancer: Furthermore, Liu et al utilized natural halloysite nanotube (HNT)–assisted delivery of an active siRNA targeting RIPK4 significantly inhibited RIPK4 expression and suppressed bladder cancer progression, with no adverse effects (Liu et al., 2019).